335 related articles for article (PubMed ID: 33631122)
1. Revealing Tissue-Specific SARS-CoV-2 Infection and Host Responses using Human Stem Cell-Derived Lung and Cerebral Organoids.
Tiwari SK; Wang S; Smith D; Carlin AF; Rana TM
Stem Cell Reports; 2021 Mar; 16(3):437-445. PubMed ID: 33631122
[TBL] [Abstract][Full Text] [Related]
2. Expression of Endogenous Angiotensin-Converting Enzyme 2 in Human Induced Pluripotent Stem Cell-Derived Retinal Organoids.
Ahmad Mulyadi Lai HI; Chou SJ; Chien Y; Tsai PH; Chien CS; Hsu CC; Jheng YC; Wang ML; Chiou SH; Chou YB; Hwang DK; Lin TC; Chen SJ; Yang YP
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525682
[TBL] [Abstract][Full Text] [Related]
3. Kidney organoids reveal redundancy in viral entry pathways during ACE2-dependent SARS-CoV-2 infection.
Vanslambrouck JM; Neil JA; Rudraraju R; Mah S; Tan KS; Groenewegen E; Forbes TA; Karavendzas K; Elliott DA; Porrello ER; Subbarao K; Little MH
J Virol; 2024 Mar; 98(3):e0180223. PubMed ID: 38334329
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.
Kettunen P; Lesnikova A; Räsänen N; Ojha R; Palmunen L; Laakso M; Lehtonen Š; Kuusisto J; Pietiläinen O; Saber SH; Joensuu M; Vapalahti OP; Koistinaho J; Rolova T; Balistreri G
J Virol; 2023 Apr; 97(4):e0014423. PubMed ID: 37039676
[TBL] [Abstract][Full Text] [Related]
5. Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium.
Jacob F; Pather SR; Huang WK; Zhang F; Wong SZH; Zhou H; Cubitt B; Fan W; Chen CZ; Xu M; Pradhan M; Zhang DY; Zheng W; Bang AG; Song H; Carlos de la Torre J; Ming GL
Cell Stem Cell; 2020 Dec; 27(6):937-950.e9. PubMed ID: 33010822
[TBL] [Abstract][Full Text] [Related]
6. Choroid plexus defects in Down syndrome brain organoids enhance neurotropism of SARS-CoV-2.
Shaker MR; Slonchak A; Al-Mhanawi B; Morrison SD; Sng JDJ; Cooper-White J; Khromykh AA; Wolvetang EJ
Sci Adv; 2024 Jun; 10(23):eadj4735. PubMed ID: 38838150
[TBL] [Abstract][Full Text] [Related]
7. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Li K; Meyerholz DK; Bartlett JA; McCray PB
mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
[TBL] [Abstract][Full Text] [Related]
8. Modifications of lipid pathways restrict SARS-CoV-2 propagation in human induced pluripotent stem cell-derived 3D airway organoids.
Tsai PH; Sun JR; Chien Y; Chan MS; Khor W; Yang HC; Huang CH; Hsiung CN; Hwa TY; Lin YY; Yeh CL; Wang ML; Yang YP; Chen YM; Tsai FT; Lee MS; Cheng YH; Tsai SK; Liu PC; Chou SJ; Chiou SH
J Adv Res; 2024 Jun; 60():127-140. PubMed ID: 37557954
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Infection and Disease Modelling Using Stem Cell Technology and Organoids.
Trevisan M; Riccetti S; Sinigaglia A; Barzon L
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652988
[TBL] [Abstract][Full Text] [Related]
10. Neurotropic Effects of SARS-CoV-2 Modeled by the Human Brain Organoids.
Ramani A; Pranty AI; Gopalakrishnan J
Stem Cell Reports; 2021 Mar; 16(3):373-384. PubMed ID: 33631123
[TBL] [Abstract][Full Text] [Related]
11. Infection of Brain Organoids and 2D Cortical Neurons with SARS-CoV-2 Pseudovirus.
Yi SA; Nam KH; Yun J; Gim D; Joe D; Kim YH; Kim HJ; Han JW; Lee J
Viruses; 2020 Sep; 12(9):. PubMed ID: 32911874
[TBL] [Abstract][Full Text] [Related]
12. A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids.
Yang L; Han Y; Nilsson-Payant BE; Gupta V; Wang P; Duan X; Tang X; Zhu J; Zhao Z; Jaffré F; Zhang T; Kim TW; Harschnitz O; Redmond D; Houghton S; Liu C; Naji A; Ciceri G; Guttikonda S; Bram Y; Nguyen DT; Cioffi M; Chandar V; Hoagland DA; Huang Y; Xiang J; Wang H; Lyden D; Borczuk A; Chen HJ; Studer L; Pan FC; Ho DD; tenOever BR; Evans T; Schwartz RE; Chen S
Cell Stem Cell; 2020 Jul; 27(1):125-136.e7. PubMed ID: 32579880
[TBL] [Abstract][Full Text] [Related]
13. Identification of SARS-CoV-2 inhibitors using lung and colonic organoids.
Han Y; Duan X; Yang L; Nilsson-Payant BE; Wang P; Duan F; Tang X; Yaron TM; Zhang T; Uhl S; Bram Y; Richardson C; Zhu J; Zhao Z; Redmond D; Houghton S; Nguyen DT; Xu D; Wang X; Jessurun J; Borczuk A; Huang Y; Johnson JL; Liu Y; Xiang J; Wang H; Cantley LC; tenOever BR; Ho DD; Pan FC; Evans T; Chen HJ; Schwartz RE; Chen S
Nature; 2021 Jan; 589(7841):270-275. PubMed ID: 33116299
[TBL] [Abstract][Full Text] [Related]
14. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
[TBL] [Abstract][Full Text] [Related]
15. A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells.
Mahoney M; Damalanka VC; Tartell MA; Chung DH; Lourenço AL; Pwee D; Mayer Bridwell AE; Hoffmann M; Voss J; Karmakar P; Azouz NP; Klingler AM; Rothlauf PW; Thompson CE; Lee M; Klampfer L; Stallings CL; Rothenberg ME; Pöhlmann S; Whelan SPJ; O'Donoghue AJ; Craik CS; Janetka JW
Proc Natl Acad Sci U S A; 2021 Oct; 118(43):. PubMed ID: 34635581
[TBL] [Abstract][Full Text] [Related]
16. ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response.
Wang C; Zhang M; Garcia G; Tian E; Cui Q; Chen X; Sun G; Wang J; Arumugaswami V; Shi Y
Cell Stem Cell; 2021 Feb; 28(2):331-342.e5. PubMed ID: 33450186
[TBL] [Abstract][Full Text] [Related]
17. Human airway lineages derived from pluripotent stem cells reveal the epithelial responses to SARS-CoV-2 infection.
Wang R; Hume AJ; Beermann ML; Simone-Roach C; Lindstrom-Vautrin J; Le Suer J; Huang J; Olejnik J; Villacorta-Martin C; Bullitt E; Hinds A; Ghaedi M; Rollins S; Werder RB; Abo KM; Wilson AA; Mühlberger E; Kotton DN; Hawkins FJ
Am J Physiol Lung Cell Mol Physiol; 2022 Mar; 322(3):L462-L478. PubMed ID: 35020534
[TBL] [Abstract][Full Text] [Related]
18. Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition.
Navaratnarajah CK; Pease DR; Halfmann PJ; Taye B; Barkhymer A; Howell KG; Charlesworth JE; Christensen TA; Kawaoka Y; Cattaneo R; Schneider JW;
J Virol; 2021 Nov; 95(24):e0136821. PubMed ID: 34613786
[TBL] [Abstract][Full Text] [Related]
19. Virological characteristics of a SARS-CoV-2-related bat coronavirus, BANAL-20-236.
Fujita S; Plianchaisuk A; Deguchi S; Ito H; Nao N; Wang L; Nasser H; Tamura T; Kimura I; Kashima Y; Suzuki R; Suzuki S; Kida I; Tsuda M; Oda Y; Hashimoto R; Watanabe Y; Uriu K; Yamasoba D; Guo Z; Hinay AA; Kosugi Y; Chen L; Pan L; Kaku Y; Chu H; Donati F; Temmam S; Eloit M; Yamamoto Y; Nagamoto T; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; Suzuki Y; ; Ito J; Ikeda T; Tanaka S; Matsuno K; Fukuhara T; Takayama K; Sato K
EBioMedicine; 2024 Jun; 104():105181. PubMed ID: 38838469
[TBL] [Abstract][Full Text] [Related]
20. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.
Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S
J Genet; 2021; 100(1):. PubMed ID: 33707363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
